RUTHERFORD BILL B 4

4 · HCA Healthcare, Inc. · Filed Feb 3, 2023

Form 4

Period: 2023-02-01

CFO and EVP

Transactions

Exercise/Conversion
Stock Appreciation Right
2023-02-01−37,000→ 0 total
Exercise: $68.96Exp: 2025-02-04→ Common Stock (37,000 underlying)
Exercise/Conversion
Common Stock
2023-02-01$69.58/sh+27,000$1,878,660→ 146,527 total
Sale
Common Stock
2023-02-03$258.19/sh−30,000$7,745,568→ 81,632 total
Exercise/Conversion
Stock Appreciation Right
2023-02-01−27,000→ 19,100 total
Exercise: $69.58Exp: 2026-01-29→ Common Stock (27,000 underlying)
Tax Payment
Common Stock
2023-02-01$261.46/sh−34,895$9,123,647→ 111,632 total
Exercise/Conversion
Common Stock
2023-02-01$68.96/sh+37,000$2,551,520→ 119,527 total

Holdings

Footnotes (3)

[F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $257.67 to $258.54, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F2]The stock appreciation rights vested in four equal annual installments beginning on February 4, 2016.
[F3]The stock appreciation rights vested in four equal annual installments beginning on January 29, 2017.

Documents

2 files